Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Trial of a Hybrid Approach for Treatment of Patients With Persistent or Longstanding Persistent Atrial Fibrillation With Radiofrequency Ablation

NCT01246466 is registered in ClinicalTrials.gov with AtriCure, Inc. as lead sponsor.

NCT NCT01246466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01246466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Trial of a Hybrid Approach for Treatment of Patients With Persistent or Longstanding Persistent Atrial Fibrillation With Radiofrequency Ablation
Lead sponsor
AtriCure, Inc.
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2010
Completion date
November 30, 2013
Enrollment
24 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

longstanding persistent atrial fibrillation, persistent atrial fibrillation